Evommune, Inc. · NYSE:EVMN
Andera Partners reported a 6.00% stake in Evommune, Inc. (Schedule 13G)
Event Nov 7, 2025 · Filed Nov 17, 2025
Andera Partners reported a 6.00% stake in Evommune, Inc., 1,897,362 shares, as a passive investor on Nov 7, 2025. Filed Nov 17, 2025 (Schedule 13G).
- Stake
- 6.00%
- Shares
- 1,897,362
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Andera Partners | 6.00% | 1,897,362 |
| BioDiscovery 6 FPCI | 6.00% | 1,897,362 |
| Stephane Bergez | 6.00% | 1,897,362 |
| Francois Xavier Mauron | 6.00% | 1,897,362 |
Source
Related
- Evommune, Inc.
- Andera Partners
- Evommune, Inc. shareholders
- Schedule 13G/A · Andera Partners · Aug 14, 2026
- Form 4 · Pena Luis C. · Oct 15, 2026
- Schedule 13G · T. Rowe Price Associates Inc · Aug 14, 2026
- Schedule 13G · Point72 Asset Management, L.P. · Jul 16, 2026
- Form 4 · Carver Kyle · Jul 10, 2026
- Form 4 · Kirsch Arthur S · Jul 8, 2026